BOL Pharma
Revadim
About BOL Pharma
BOL Pharma (BOL) has been pioneering the creation of the medical cannabis industry in israel since 2007. The company sources 99% pure pharma grade CBD, THC, and other active ingredients from its own organic GAP certified growing facilities and cGMP certified production plant. Working in conjuction with Israel’s Ministry of Health and under governmental license, BOL serves thousands of patients, doctors, HMOs, and hospitals providing cannabis based medical products and cannabinoid active pharmaceutical ingredients (APIs). As a full service contract manufacturer, BOL produces formulations for clinical research and white label services for the pharmaceuticals, food, supplements, and cosmetics industries. BOL’s seasoned management team of professionals, medical experts, and researchers bring a wealth of experience and expertise in clinical research, precision agriculture, production and marketing of pharma and health products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $30.0M
- Last round: Convertible Note (Dec 2018)
- Website: bolpharma.com
- Phone: +972 2129810355
Industries & Categories
Health Care, Manufacturing, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bol-pharma-139029 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.